Improving Colonoscopy for CRC Screening

Slides:

Advertisements

Similar presentations

Benchmarking For Colonoscopy

Advertisements

Fostering a Collaborative Approach in the Management of BRCA-Mutated Ovarian Cancer.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Clinical Trials in IBD.

Psoriatic Arthritis.

A Review of the Critical Role of Imaging in Primary Liver Malignancy

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data.

Why Gene Therapy for Hemophilia?

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.

Advances in Managing Inhibitors in Patients With Hemophilia A

5 Things NPs and PAs Need to Know About Tardive Dyskinesia

Exploring the Spectrum of Excessive Daytime Sleepiness

Improving Quality Measures for Colonoscopy and CRC Prevention

Updates on Emerging GLP-1 Receptor Agonists

CRC Screening and Quality of Colonoscopy

Progression After Cancer Immunotherapy in Advanced NSCLC

Chronic Rhinosinusitis

Residual Paralysis Is More Common Than You Think

COPD Management.

Why Treat Seborrheic Keratosis?

Case Challenges in Chronic Migraine

Updates in Management of Atopic Dermatitis From Real Patient Cases

Before and After: Patient Cases in Onychomycosis

Induction Chemotherapy for Patients With High-Risk or Secondary AML

Essential Concepts in the Screening and Detection of Colorectal Cancer

Differentiating Among the CDK 4/6 Inhibitors in the Management of Metastatic Breast Cancer.

The Resurgence of Topical Treatments Across a Spectrum of Psoriasis

Chronic Idiopathic Urticaria

Addressing Disease Burden in Asthma

Asthma and Atopic Comorbidities

The Evolving Role of Immunotherapy in NSCLC

Optimizing Management of Advanced Bladder Cancer

Postpartum Depression

Multidisciplinary Perspectives on Interstitial Lung Diseases

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Next-Gen Psoriasis Therapies:

Management of CMV in HSCT Recipients

Evaluating Next-Generation BTK Inhibitors

Case Studies in Unresectable Hepatocellular Carcinoma

Hyperhidrosis Is Burdensome!

Gene Therapy: Past, Present, and Future

Emerging Atopic Dermatitis Treatments:

Ask the Experts.

Immunotherapy for cSCC

Perspectives on the Impact of Inflammation in OA

New Recommendations on How to Stage Hidradenitis Suppurativa

When Is Biologic Therapy Appropriate for HS?

Personalizing Management in the Care of Patients With Advanced Sarcoma

Goals. Weight Management Goals and Approaches in Patients With Type 2 Diabetes.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States and data.

Developments in the Wet AMD Treatment Landscape

Parkinson Disease Psychosis

Talking With Your Patients About Excessive Sweating

When to Start and What to Use

Immune Checkpoint Inhibitors in Lung Cancer

Guide to Atopic Dermatitis

Patient Questions and Expert Answers in Psoriasis:

Optimizing Joint Health in Hemophilia

Novel Concepts in the Management of RCC

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.

From Adjuvant to Metastatic in Melanoma

Mo1704 NEW TECHNOLOGY DEVICES INCREASE SESSILE SERRATED ADENOMA DETECTION RATE IN COLONOSCOPY – A SYSTEMATIC REVIEW AND META- ANALYSIS Elijah Verheyen,

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition

HAE Prophylaxis.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Immune Checkpoint Inhibitors in Lung Cancer

Expert Insights in Diagnosis and Management of Common Drug-Induced Movement Disorders.

Foundations of Asthma.

Presentation transcript:

Improving Colonoscopy for CRC Screening

This program will include a discussion of off-label and investigational agents not approved by the FDA for use in the United States.

CRC Incidence

Overview of CRC Screening

Screening Colonoscopy and CRC Prevention

Colonoscopy and CRC Prevention German and US Data

Colonoscopy Is Operator-Dependent

Pathologist Impact on Polyp Detection

Conventional Adenomas

Sessile-Serrated Polyps

Adenoma Detection Rate

Why Is ADR So Important?

Colonoscopy Benchmarking What Should be Measured?

How Can ADR Be Improved?

Improving Colonoscopy Quality MSTF Tools for Patients

Technologies That Can Improve Detection

Chromoendoscopy

Electronic Chromoendoscopy With NBI

Chromocolonoscopy vs HDWL Colonoscopy

Chromoendoscopy With Methylene Blue MMX

Chromoendoscopy With Methylene Blue MMX* (cont)

Cap-Assisted Colonoscopy

Fold-Flattening Devices

Comparison Study of Standard HD, Endocuff, EndoRings, Fuse®

Endocuff Vision Hepatic Flexure

EndoRings

Concluding Remarks

Concluding Remarks (cont)

Abbreviations